FOXO TECHNOLOGIES INC.

FOXO Technologies Inc. (NYSE American: FOXO) is an insurtech company that completed its de-SPAC business combination with CF Acquisition Corp VIII in September 2022, with Cantor Fitzgerald serving as sponsor. The company operates in the life insurance technology sector, applying epigenetic biomarker science and artificial intelligence to modernize underwriting and policyholder engagement for life insurers. FOXO went public in 2022 and has remained a reporting company, filing an 8-K with the SEC on July 27, 2026. The company continues to navigate the competitive insurtech landscape as a post-merger public entity. For full filing history, deal timelines, and real-time analytics on FOXO and the broader SPAC universe, sign up for complete data access at SpacDesk.